Mohammad G Saklayen
Overview
Explore the profile of Mohammad G Saklayen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
1735
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saklayen M
Curr Hypertens Rep
. 2018 Feb;
20(2):12.
PMID: 29480368
Metabolic syndrome, variously known also as syndrome X, insulin resistance, etc., is defined by WHO as a pathologic condition characterized by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia. Though there...
2.
Weiner D, Gaussoin S, Nord J, Auchus A, Chelune G, Chonchol M, et al.
Am J Kidney Dis
. 2017 Jun;
70(3):357-367.
PMID: 28606731
Background: Chronic kidney disease is common and is associated with cardiovascular disease, cerebrovascular disease, and cognitive function, although the nature of this relationship remains uncertain. Study Design: Cross-sectional cohort using...
3.
Braam B, Taler S, Rahman M, Fillaus J, Greco B, Forman J, et al.
Clin J Am Soc Nephrol
. 2016 Nov;
12(3):524-535.
PMID: 27895136
Despite improvements in hypertension awareness and treatment, 30%-60% of hypertensive patients do not achieve BP targets and subsequently remain at risk for target organ damage. This therapeutic gap is particularly...
4.
Currie G, Taylor A, Fujita T, Ohtsu H, Lindhardt M, Rossing P, et al.
BMC Nephrol
. 2016 Sep;
17(1):127.
PMID: 27609359
Background: Hypertension and proteinuria are critically involved in the progression of chronic kidney disease. Despite treatment with renin angiotensin system inhibition, kidney function declines in many patients. Aldosterone excess is...
5.
Saklayen M, Deshpande N
Front Cardiovasc Med
. 2016 Mar;
3:3.
PMID: 26942184
It is surprising that only about 50 years ago hypertension was considered an essential malady and not a treatable condition. Introduction of thiazide diuretics in late 50s made some headway...
6.
Reisin E, Graves J, Yamal J, Barzilay J, Pressel S, Einhorn P, et al.
J Hypertens
. 2014 May;
32(7):1503-13.
PMID: 24842697
Objective: Epidemiologically, there is a strong relationship between BMI and blood pressure (BP) levels. We prospectively examined randomization to first-step chlorthalidone, a thiazide-type diuretic; amlodipine, a calcium-channel blocker; and lisinopril,...
7.
8.
9.
Piller L, Baraniuk S, Simpson L, Cushman W, Massie B, Einhorn P, et al.
Circulation
. 2011 Oct;
124(17):1811-8.
PMID: 21969009
Background: In the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), a randomized, double-blind, practice-based, active-control, comparative effectiveness trial in high-risk hypertensive participants, risk of new-onset heart failure...
10.
Abbass K, Jaffery A, Markert R, Saklayen M, Khan N
Int Urol Nephrol
. 2011 Jul;
44(4):1293-4.
PMID: 21779918
No abstract available.